- Home
- AVIR vs ONEW Comparison
AVIR vs ONEW Comparison
Compare AVIR & ONEW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVIR
- ONEW
- Stock Information
- Founded
- AVIR 2012
- ONEW 2014
- Country
- AVIR United States
- ONEW United States
- Employees
- AVIR N/A
- ONEW N/A
- Industry
- AVIR Medicinal Chemicals and Botanical Products
- ONEW Auto & Home Supply Stores
- Sector
- AVIR Health Care
- ONEW Consumer Discretionary
- Exchange
- AVIR Nasdaq
- ONEW Nasdaq
- Market Cap
- AVIR 290.4M
- ONEW 284.0M
- IPO Year
- AVIR 2020
- ONEW 2020
- Fundamental
- Price
- AVIR $2.97
- ONEW $15.96
- Analyst Decision
- AVIR Hold
- ONEW Buy
- Analyst Count
- AVIR 1
- ONEW 8
- Target Price
- AVIR $6.00
- ONEW $19.43
- AVG Volume (30 Days)
- AVIR 223.7K
- ONEW 98.5K
- Earning Date
- AVIR 11-06-2025
- ONEW 11-13-2025
- Dividend Yield
- AVIR N/A
- ONEW N/A
- EPS Growth
- AVIR N/A
- ONEW N/A
- EPS
- AVIR N/A
- ONEW N/A
- Revenue
- AVIR N/A
- ONEW $1,790,054,000.00
- Revenue This Year
- AVIR N/A
- ONEW $4.76
- Revenue Next Year
- AVIR N/A
- ONEW $3.23
- P/E Ratio
- AVIR N/A
- ONEW N/A
- Revenue Growth
- AVIR N/A
- ONEW N/A
- 52 Week Low
- AVIR $2.46
- ONEW $11.58
- 52 Week High
- AVIR $4.10
- ONEW $26.78
- Technical
- Relative Strength Index (RSI)
- AVIR 33.48
- ONEW 47.75
- Support Level
- AVIR $2.84
- ONEW $15.44
- Resistance Level
- AVIR $3.33
- ONEW $16.77
- Average True Range (ATR)
- AVIR 0.14
- ONEW 0.58
- MACD
- AVIR -0.04
- ONEW -0.14
- Stochastic Oscillator
- AVIR 18.98
- ONEW 31.14
About AVIR Atea Pharmaceuticals Inc.
Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics to improve the lives of patients suffering from serious viral infections. The company is developing its product candidate, bemnifosbuvir, for the treatment of COVID-19, the disease caused by infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and its variants and also developing bemnifosbuvir in combination with ruzasvir for the treatment of Hepatitis C (HCV).
About ONEW OneWater Marine Inc.
OneWater Marine Inc is a recreational marine retailer in the United States. The company operates in two segments: Dealership and Distribution. The Dealership segment is involved in selling new and pre-owned boats. It also arranges financing and insurance products, provides repairs and maintenance services, offers marine-related parts and accessories, and supplies slip and storage accommodations at certain locations. The Distribution segment focuses on the manufacturing, assembly, and distribution of marine-related products. These products are supplied to distributors, box retailers, and online retailers through a network of warehouses and distribution centers. The company generates the majority of its revenue from the Dealership segment.